X4 Pharmaceuticals (XFOR) Preferred Dividend Payments (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted Preferred Dividend Payments of -$9000.0 for Q4 2025, up 55.0% on a QoQ basis from -$20000.0 in Q3 2025, and down 212.5% year-over-year from $8000.0 in Q4 2024.
X4 Pharmaceuticals (XFOR) Preferred Dividend Payments (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' Preferred Dividend Payments history runs 6 years deep, the most recent figure standing at -$9000.0 for Q4 2025.
- Quarterly Preferred Dividend Payments fell 212.5% year-over-year to -$9000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$13000.0 (down 360.0% YoY) and the FY2025 annual result came in at -$13000.0, down 533.33% from the prior year.
- Preferred Dividend Payments was -$9000.0 for Q4 2025 at X4 Pharmaceuticals, up from -$20000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $2.3 million in Q1 2022 and bottomed at -$45000.0 in Q3 2024.
- A 3-year average of $253800.0 and a median of $7000.0 in 2024 frame the typical range for Preferred Dividend Payments.
- Peak annual rise in Preferred Dividend Payments reached 66.67% in 2025, while the deepest fall reached 212.5% in 2025.
- X4 Pharmaceuticals' Preferred Dividend Payments stood at $287000.0 in 2022, then sank by 97.21% to $8000.0 in 2024, then sank by 212.5% to -$9000.0 in 2025.
- Business Quant data shows XFOR's Preferred Dividend Payments at -$9000.0 in Q4 2025, -$20000.0 in Q3 2025, and $10000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | -9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | -20,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Sep 30, 2022 | 287,000.00 |
| Mar 31, 2022 | 2.26 Mn |
| Dec 31, 2019 | -592,000.00 |
| Mar 31, 2019 | 592,000.00 |
| Dec 31, 2018 | 2.98 Mn |
| Jun 30, 2018 | 748,000.00 |
| Mar 31, 2018 | 22,000.00 |
| Dec 31, 2017 | 2.96 Mn |
| Sep 30, 2017 | 16,000.00 |
| Jun 30, 2017 | 13,000.00 |
| Mar 31, 2017 | 7,000.00 |